Resistance to thyroid hormone (RTH) is a clinical syndrome defined by impaired sensitivity
to thyroid hormone (TH) and its more common form is caused by mutations in the thyroid …

Background and aims Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare
entity, occurring in one per million people. We performed a systematic review of 535 adult …

Inappropriate secretion of TSH was first described in 1960 in a patient with evidence of
hyperthyroidism and expanded sella on imaging. It was later found that a type of pituitary …

Background Growth hormone (GH)/thyroid stimulating hormone (TSH) cosecreting pituitary
adenoma (PA) is an exceedingly rare kind of bihormonal pituitary neuroendocrine tumors …

Normal or elevated thyrotropin (TSH) levels in hyperthyroid patients are characteristic of rare
TSH-secreting pituitary adenoma (TSH-oma), which is easily detectable by computed …

Resistance to thyroid hormone (RTH), a syndrome of reduced responsiveness of target
tissues to thyroid hormone (TH) was identified in 1967 (1). An early report proposed various …

Undifferentiated thyroid carcinoma is one of the most aggressive human cancers with
frequent RAS mutations. How mutations of the RAS gene contribute to undifferentiated …

Over the past decade, knowledge of the potential role of TSH in the development of
differentiated thyroid cancer has expanded. In addition, the therapeutic role of TSH has …

Background Thyroid stimulating hormone (TSH) secreting pituitary adenoma (TSHoma) with
coexisting thyroid cancer is extremely rare, and proper treatment of both diseases may pose …

Background: Patients with a thyrotropin-secreting pituitary adenoma (TSHoma) are exposed
to unregulated and inappropriately high levels of thyrotropin (TSH). Given the rarity of this …